Md. prescription drug price bill poses threat, industry warns

ANNAPOLIS -- Drug manufacturers warned legislators Wednesday that a proposal aimed at keeping prescription drug prices low could harm Maryland’s biotechnology industry. The legislation would create a commission to review drug prices in Maryland, but that could decrease outside investment in the state’s industry, advocates said. “(The legislation would) take away incentives for manufacturers to invent,” ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *